Taking stock of the drug industry, from the lab to the medicine chest Sponsored by STAT+: The FDA says it's in the dark about thousands of dietary supplement ingredients By Nicholas Florko Adobe Despite a law requiring them to do so, supplement makers haven’t notified the FDA about roughly 3,400 ingredients they’re selling. Read More As reports of 'Paxlovid rebound' increase, Covid researchers scramble for answers By Jason Mast Bloomberg photo by Kobi Wolf These cases raise important questions about how doctors should use Paxlovid, the most effective Covid-19 treatment to date. Read More Opinion: STAT+: A market failure is preventing efficient diffusion of health care AI software By Mark P. Sendak and Nicholson Price and Suresh Balu Adobe Without change, low-resource hospitals will adopt poorly functioning AI software, and markets for best-in-class software will fail to emerge. Read More Tuesday, May 24, 2022 1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser
No comments